Very safe profile in clinical trials. Cholinergic: headache, nausea at high doses. Drug interactions: levodopa (additive benefit but monitor). Generally very safe at 250-1000mg/day.
Nucleoside derivative providing both cytidine and choline. Phospholipid precursor for brain membrane synthesis. Used for stroke recovery, traumatic brain injury, and cognitive enhancement. Approved pharmaceutical in several countries (Ceraxon, Somazina).
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)